McKesson Corporation

Healthcare · Medical Distribution

874.70$ -0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

McKesson Corporation (MCK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 403,430 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MCK
Line item	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	12,887	20,857	30,382	36,734	42,010	50,006	57,121	69,506	80,515	88,050	92,977	101,703	106,632	108,702	112,084	122,734	122,455	137,609	179,045	190,884	198,533	208,357	214,319	231,051	238,228	263,966	276,711	308,951	359,051	403,430
Cost of Revenue	11,778	19,249	27,517	34,211	39,579	47,209	54,018	66,258	76,670	83,206	88,640	96,703	101,249	103,021	106,093	116,307	115,704	129,571	168,116	179,941	187,845	197,965	203,557	219,651	226,646	251,317	264,842	296,749	346,566	388,880
Gross Profit	1,109	1,609	2,865	2,524	2,431	2,797	3,103	3,248	3,450	3,777	4,337	5,000	5,383	5,681	5,991	6,427	6,751	8,038	10,929	10,943	10,688	10,392	10,762	11,400	11,582	12,649	11,869	12,202	12,485	14,550
Research & Development	–	–	115	113	148	135	149	173	182	223	284	347	364	376	407	440	480	456	392	392	341	125	71	96	74	70	89	77	91	103
Selling, General & Administrative	945	1,159	2,219	2,052	2,076	1,946	2,023	2,092	2,273	2,480	2,790	3,189	3,075	2,566	2,762	3,065	2,351	5,418	7,901	7,276	7,466	8,138	7,486	18,336	17,698	21,074	15,552	6,910	8,507	8,096
Total Operating Expenses	1,016	1,246	2,533	2,366	2,335	2,103	2,173	2,265	2,445	2,606	3,053	3,522	3,661	3,671	3,893	4,047	4,331	5,388	7,398	7,092	7,331	7,471	7,684	8,388	8,072	9,926	7,416	8,275	8,113	8,096
Operating Income	93	362	332	158	96	694	930	983	1,005	1,171	1,284	1,478	1,722	2,010	2,098	2,380	2,420	2,650	3,531	3,851	3,357	2,921	3,078	3,012	3,510	2,723	4,453	3,927	4,372	6,454
Interest Expense	0.0	0.0	0.0	0.0	0.0	113	115	120	118	94	99	142	144	187	197	251	229	257	374	353	308	283	264	249	217	178	248	243	256	247
Pre-Tax Income	36	254	202	307	9.6	601	855	911	-245	1,171	1,297	1,457	1,064	1,864	1,635	1,919	1,919	2,096	2,657	3,250	6,891	239	610	1,144	-5,034	1,928	4,630	3,789	4,359	6,201
Income Tax Expense	31	99	117	122	52	183	293	265	-83	421	329	468	241	601	505	516	581	742	815	908	1,614	-53	356	18	-695	636	905	629	878	1,102
Net Income	134	155	85	724	-48	419	555	647	-157	738	963	990	823	1,263	1,130	1,403	1,338	1,263	1,476	2,258	5,183	67	34	900	-4,539	1,114	3,560	3,002	3,295	4,762
EBITDA	165	449	532	332	450	905	930	1,208	122	1,527	1,691	1,970	1,649	2,525	2,328	2,721	2,739	3,057	4,048	4,488	8,109	1,473	1,823	2,315	-3,596	3,107	5,735	4,667	5,251	7,177

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings